WEAVER GREGORY L
SEC CIK 1251779 · EDGAR
BoughtSold
Most active insiders at ALT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Durso Jerome Benedict | Pres, CEO, Dir | $213.8K | — |
| 2 | GILL JOHN | Dir | $82.6K | — |
| 3 | WEAVER GREGORY L | CFO | $49.2K | — |
| 4 | Pisano Wayne | Dir | $20.4K | — |
| 5 | Sohn Catherine A. | Dir | $2,120 | — |
| 6 | Jorkasky Diane | Dir | $2,003 | — |
| 7 | Jordt Raymond M | Chief Business Off | — | — |
| 8 | Roberts M Scot | CSO | — | — |
| 9 | Richardson Linda M | Chief Commercial Off | — | — |
| 10 | Garg Vipin K | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-03 16:05 | 2026-07-31 | ALT | Altimmune, Inc. | WEAVER GREGORY L | CFO | A - Grant | $2.41 | +1,753 | 39.8K | +5% | +$4,232 | |
| 2026-04-01 16:05 | 2026-04-01 | ALT | Altimmune, Inc. | WEAVER GREGORY L | CFO | P - Purchase | $3.15 | +10.0K | 38.1K | +36% | +$31.5K | |
| 2026-03-09 | 2026-03-06 | ALT | Altimmune, Inc. | WEAVER GREGORY L | CFO | P - Purchase | $3.54 | +5,000 | 28.1K | +22% | +$17.7K | |
| D | 2025-11-12 | 2025-11-11 | ALT | Altimmune, Inc. | WEAVER GREGORY L | CFO | F - Tax | $4.28 | -5,672 | 23.1K | -20% | -$24.3K |
| D | 2025-11-12 | 2025-11-11 | ALT | Altimmune, Inc. | WEAVER GREGORY L | CFO | M - OptEx | $0.00 | +18.8K | 28.8K | +188% | $0 |
| 2025-03-14 | 2025-03-13 | ALT | Altimmune, Inc. | WEAVER GREGORY L | CFO | P - Purchase | $5.20 | +10.0K | 10.0K | New | +$52.0K | |
| 2023-11-17 | 2023-11-15 | ATOS | ATOSSA THERAPEUTICS, INC. | WEAVER GREGORY L | CFO, Former EVP, Dir | S - Sale | $0.65 | -50.0K | 55 | -100% | -$32.5K | |
| 2023-06-20 | 2023-06-20 | ATOS | ATOSSA THERAPEUTICS, INC. | WEAVER GREGORY L | EVP, CFO, Dir | P - Purchase | $0.97 | +50.0K | 50.1K | +90,909% | +$48.5K | |
| DM | 2021-07-07 | 2021-07-02 | ATOS | ATOSSA THERAPEUTICS, INC. | WEAVER GREGORY L | Dir | M - OptEx | $2.22 | +164.6K | 164.6K | New | +$365.3K |
| D | 2021-07-07 | 2021-07-02 | ATOS | ATOSSA THERAPEUTICS, INC. | WEAVER GREGORY L | Dir | S - Sale+OE | $5.58 | -107.5K | 0 | -100% | -$599.8K |
| D | 2021-07-07 | 2021-07-02 | ATOS | ATOSSA THERAPEUTICS, INC. | WEAVER GREGORY L | Dir | F - Tax | $6.40 | -57.1K | 107.5K | -35% | -$365.3K |
Purchase Sale Sale after option exercise All abbreviations